HSBC Holdings’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

HSBC Holdings’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-488,473	Closed	-$7.3M	–	3287
2022 Q4	$7.3M	Buy	+488,473	New	+$6.76M	0.01%	1090
2021 Q1	–	Sell	-21,897	Closed	-$125K	–	3311
2020 Q4	$125K	Buy	21,897 +525	+2%	+$3.01K	﹤0.01%	2917
2020 Q3	$128K	Hold	21,372	–	–	﹤0.01%	2586
2020 Q2	$110K	Buy	+21,372	New	+$135K	﹤0.01%	2506
2013 Q4	–	Sell	-15,000	Closed	-$309K	–	1745
2013 Q3	$309K	Hold	15,000	–	–	﹤0.01%	1503
2013 Q2	$375K	Buy	+15,000	New	+$641K	﹤0.01%	1263

HSBC Holdings's AVEO Position: Q1 2023 in Review

HSBC Holdings sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 488,473 shares — an estimated $7.3M sold.

HSBC Holdings first reported a position in AVEO in Q2 2013 and held it in 6 quarters. The position peaked at $7.3M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

HSBC Holdings reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
HSBC Holdings sold 488,473 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $7.3M.
HSBC Holdings first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 6 quarters.
HSBC Holdings's AVEO Pharmaceuticals, Inc. position peaked at $7.3M in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on HSBC Holdings's 13F filing for Q1 2023, filed 15 May 2023.